Drug Profile
Syringomycin E
Latest Information Update: 15 Jun 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antifungals
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses